Risk‐reducing salpingo‐oophorectomy (RRSO) vs no RRSO according to BRCA mutation status
HGSC mortality: BRCA2 only
1 finding from 1 review
- Risk‐reducing bilateral salpingo‐oophorectomy in women with BRCA1 or BRCA2 mutations 2018 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 1983 participantsVery low